메뉴 건너뛰기




Volumn 4, Issue 2, 2015, Pages 114-118

Successful treatment of parainfluenza virus respiratory tract infection with DAS181 in 4 immunocompromised children

Author keywords

Antiviral therapy; Hematopoietic cell transplantation; Parainfluenza virus

Indexed keywords

ANTIVIRUS AGENT; DAS181; UNCLASSIFIED DRUG; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; HYBRID PROTEIN;

EID: 85006210393     PISSN: 20487193     EISSN: 20487207     Source Type: Journal    
DOI: 10.1093/jpids/piu039     Document Type: Article
Times cited : (41)

References (11)
  • 1
    • 79960225834 scopus 로고    scopus 로고
    • Changing epidemiology of respiratoryviral infections in hematopoietic cell transplant recipients andsolid organ transplant recipients
    • Renaud C, Campbell AP. Changing epidemiology of respiratoryviral infections in hematopoietic cell transplant recipients andsolid organ transplant recipients. Curr Opin Infect Dis 2011;24:333-43.
    • (2011) Curr Opin Infect Dis , vol.24 , pp. 333-343
    • Renaud, C.1    Campbell, A.P.2
  • 2
    • 0035437136 scopus 로고    scopus 로고
    • Parainfluenza virus infectionsafter hematopoietic stem cell transplantation: risk factors,response to antiviral therapy, and effect on transplant outcome
    • Nichols WG, Corey L, Gooley T, et al. Parainfluenza virus infectionsafter hematopoietic stem cell transplantation: risk factors,response to antiviral therapy, and effect on transplant outcome.Blood 2001; 98:573-8.
    • (2001) Blood , vol.98 , pp. 573-578
    • Nichols, W.G.1    Corey, L.2    Gooley, T.3
  • 3
    • 33645765519 scopus 로고    scopus 로고
    • Sialidase fusionprotein as a novel broad-spectrum inhibitor of influenza virusinfection
    • Malakhov MP, Aschenbrenner LM, Smee DF, et al. Sialidase fusionprotein as a novel broad-spectrum inhibitor of influenza virusinfection. Antimicrob Agents Chemother 2006; 50:1470-9.
    • (2006) Antimicrob Agents Chemother , vol.50 , pp. 1470-1479
    • Malakhov, M.P.1    Aschenbrenner, L.M.2    Smee, D.F.3
  • 4
    • 84870226652 scopus 로고    scopus 로고
    • A phase II study ofDAS181, a novel host directed antiviral for the treatment of influenzainfection
    • Moss RB, Hansen C, Sanders RL, et al. A phase II study ofDAS181, a novel host directed antiviral for the treatment of influenzainfection. J Infect Dis 2012; 206:1844-51.
    • (2012) J Infect Dis , vol.206 , pp. 1844-1851
    • Moss, R.B.1    Hansen, C.2    Sanders, R.L.3
  • 5
    • 77954573573 scopus 로고    scopus 로고
    • A recombinant sialidasefusion protein effectively inhibits human parainfluenza viral infectionin vitro and in vivo
    • Moscona A, Porotto M, Palmer S, et al. A recombinant sialidasefusion protein effectively inhibits human parainfluenza viral infectionin vitro and in vivo. J Infect Dis 2010; 202:234-41.
    • (2010) J Infect Dis , vol.202 , pp. 234-241
    • Moscona, A.1    Porotto, M.2    Palmer, S.3
  • 6
    • 84886044415 scopus 로고    scopus 로고
    • Inhibition of primary clinicalisolates of human parainfluenza virus by DAS181 in cell cultureand in a cotton rat model
    • Jones BG, Hayden RT, Hurwitz JL. Inhibition of primary clinicalisolates of human parainfluenza virus by DAS181 in cell cultureand in a cotton rat model. Antiviral Res 2013; 100:562-6.
    • (2013) Antiviral Res , vol.100 , pp. 562-566
    • Jones, B.G.1    Hayden, R.T.2    Hurwitz, J.L.3
  • 7
    • 80052430780 scopus 로고    scopus 로고
    • Treatment of parainfluenza3 infection with DAS181 in a patient after allogeneic stem celltransplantation
    • Chen YB, Driscoll JP, McAfee SL, et al. Treatment of parainfluenza3 infection with DAS181 in a patient after allogeneic stem celltransplantation. Clin Infect Dis 2011; 53:e77-80.
    • (2011) Clin Infect Dis , vol.53 , pp. e77-80
    • Chen, Y.B.1    Driscoll, J.P.2    McAfee, S.L.3
  • 8
    • 84865185321 scopus 로고    scopus 로고
    • Clinical potentialof DAS181 for treatment of parainfluenza-3 infections intransplant recipients
    • Guzman-Suarez BB, BuckleyMW, Gilmore ET, et al. Clinical potentialof DAS181 for treatment of parainfluenza-3 infections intransplant recipients. Transpl Infect Dis 2012; 14:427-33.
    • (2012) Transpl Infect Dis , vol.14 , pp. 427-433
    • Guzman-Suarez, B.B.1    Buckley, M.W.2    Gilmore, E.T.3
  • 9
    • 84873416182 scopus 로고    scopus 로고
    • DAS181 treatment ofsevere parainfluenza type 3 pneumonia in a lung transplant recipient
    • Drozd DR, Limaye AP, Moss RB, et al. DAS181 treatment ofsevere parainfluenza type 3 pneumonia in a lung transplant recipient.Transpl Infect Dis 2013; 15:E28-32.
    • (2013) Transpl Infect Dis , vol.15 , pp. E28-32
    • Drozd, D.R.1    Limaye, A.P.2    Moss, R.B.3
  • 10
    • 33746366176 scopus 로고    scopus 로고
    • Comparison of real-timePCR assays with fluorescent-antibody assays for diagnosis of respiratoryvirus infections in children
    • Kuypers J,Wright N, Ferrenberg J, et al. Comparison of real-timePCR assays with fluorescent-antibody assays for diagnosis of respiratoryvirus infections in children. J Clin Microbiol 2006; 44:2382-8.
    • (2006) J Clin Microbiol , vol.44 , pp. 2382-2388
    • Kuypers, J.1    Wright, N.2    Ferrenberg, J.3
  • 11
    • 64149119175 scopus 로고    scopus 로고
    • Parainfluenza virus infectionof young children: estimates of the population-based burdenof hospitalization
    • Weinberg GA, Hall CB, Iwane MK, et al. Parainfluenza virus infectionof young children: estimates of the population-based burdenof hospitalization. J Pediatr 2009; 154:694-9.
    • (2009) J Pediatr , vol.154 , pp. 694-699
    • Weinberg, G.A.1    Hall, C.B.2    Iwane, M.K.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.